Similar Articles
1701 Antitumor activity of an hTERT promoter-regulated tumor-selective oncolytic adenovirus in human hepatocellular carcinoma
1702 Hepatocellular carcinoma prevention: A worldwide emergence between the opulence of developed countries and the economic constraints of developing nations
1703 Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: A multicenter study of 412 patients
1704 Efficacy and safety of thalidomide in patients with hepatocellular carcinoma
1705 Milan criteria are useful predictors for favorable outcomes in hepatocellular carcinoma patients undergoing liver transplantation after transarterial chemoembolization
1706 Precore/basal core promoter mutants and hepatitis B viral DNA levels as predictors for liver deaths and hepatocellular carcinoma
1707 Chemokine expression in hepatocellular carcinoma versus colorectal liver metastases
1708 Hepatocellular carcinoma metastasizing to the skull base involving multiple cranial nerves
1709 A case of hepatocellular carcinoma arising within large focal nodular hyperplasia with review of the literature
1710 Activation of c-Yes in hepatocellular carcinoma: A preliminary study
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA